Related by context. Frequent words. (Click for all words.) 71 refractory chronic lymphocytic 69 BrachySil 69 CCX# 69 Azedra 69 Panzem R 69 R sorafenib tablets 69 RGB # 68 Azixa 68 IMC #B 68 dacetuzumab 68 PXD# 67 elotuzumab 67 CORT # 67 TOCOSOL Paclitaxel 67 bafetinib 67 Entereg R 67 proteasome inhibitor 67 DAVANAT 67 HGS ETR1 67 ThermoDox R 67 JAK1 67 Nanobody 67 nonclinical studies 66 Allovectin 7 R 66 forodesine 66 talactoferrin 66 liposomal formulation 66 Bicifadine 66 MGCD# MGCD# [002] 66 tezampanel 66 DDP# 66 SARMs 66 Factor VIIa 66 MOZOBIL 66 deforolimus 66 KRN# 66 ganetespib 66 optical biosensors 65 tanespimycin 65 Daclizumab 65 Sym# 65 nitric oxide donating 65 efficacy tolerability 65 BNC# 65 ALN TTR# 65 Traficet EN 65 Neuradiab 65 NGX# 65 Golimumab 65 GVAX R 65 Dapagliflozin 65 Bioenvision compounds under 65 INCB# [001] 65 BEMA TM Fentanyl 65 Aurora kinase 65 squalamine 65 Copegus R 65 orally bioavailable 65 investigational compounds 64 ICA # 64 omecamtiv mecarbil 64 pertuzumab 64 Nexavar ® 64 OncoVEX GM CSF 64 ASONEP 64 bicifadine 64 rNAPc2 64 Perifosine 64 IMC A# 64 R bortezomib 64 enzastaurin 64 Vilazodone 64 oncology indications 64 Chrysalin 64 Phase 1b trial 64 Stedivaze 64 brostallicin 64 Mipomersen 64 Cloretazine R VNP#M 64 ELND# 64 PS# [001] 63 multi kinase inhibitor 63 Tesetaxel 63 Phase Ib II 63 Fibrillex TM 63 vascular disrupting agent 63 ATL# [001] 63 SAR# [004] 63 BZL# 63 eprotirome 63 preclinical compounds 63 cancer immunotherapies 63 Cetrorelix 63 phase IIb clinical 63 PSN# [002] 63 MGCD# [001] 63 immunological diseases 63 Phase 2b clinical trials 63 pharmacokinetic properties 63 therapeutic monoclonal antibodies 63 iSONEP